The risk or severity of adverse effects can be increased when Ibuprofen is combined with Mizoribine. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Serrapeptase. Ibuprofen may decrease the antihypertensive activities of Timolol. The risk or severity of adverse effects can be increased when Spirapril is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Risedronate. The therapeutic efficacy of Beraprost can be decreased when used in combination with Ibuprofen. The risk or severity of adverse effects can be increased when Suprofen is combined with Ibuprofen. Ibuprofen may increase the anticoagulant activities of Dextran 40. The metabolism of Ibuprofen can be decreased when combined with Quinine. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fluocinonide. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Loteprednol. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Cortexolone 17α-propionate. The risk or severity of adverse effects can be increased when Valdecoxib is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Telmisartan is combined with Ibuprofen. The metabolism of Ibuprofen can be decreased when combined with Celecoxib. The metabolism of Ibuprofen can be decreased when combined with Tolbutamide. The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ibuprofen. Ibuprofen may decrease the antihypertensive activities of Celiprolol. The serum concentration of Digoxin can be increased when it is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Ciclesonide. The therapeutic efficacy of Dinoprostone can be decreased when used in combination with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Nitroaspirin. The metabolism of Ibuprofen can be decreased when combined with Citalopram. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Haloperidol. The metabolism of Ibuprofen can be decreased when combined with Eslicarbazepine acetate. The metabolism of Ibuprofen can be decreased when combined with Lapatinib. The risk or severity of adverse effects can be increased when Enalapril is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with E-6201. The metabolism of Ibuprofen can be decreased when combined with Esomeprazole. The metabolism of Ibuprofen can be decreased when combined with Bortezomib. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Pamidronate. Ibuprofen may decrease the antihypertensive activities of Befunolol. The therapeutic efficacy of Quinethazone can be decreased when used in combination with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Magnesium salicylate. The risk or severity of bleeding can be increased when Betrixaban is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Medrysone. Ibuprofen may increase the neuroexcitatory activities of Nalidixic Acid. The metabolism of Ibuprofen can be increased when combined with Phenobarbital. Ibuprofen may decrease the antihypertensive activities of Sotalol. The risk or severity of adverse effects can be increased when Ketoprofen is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Eprosartan is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Zofenopril is combined with Ibuprofen. Ibuprofen may increase the nephrotoxic activities of Cyclosporine. The metabolism of Ibuprofen can be decreased when combined with Sulfamethoxazole. Ibuprofen may increase the anticoagulant activities of Dabigatran etexilate. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Clodronic Acid. The serum concentration of Ibuprofen can be increased when it is combined with Ranolazine. Sarilumab may increase the immunosuppressive activities of Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Propacetamol. Ibuprofen may decrease the excretion rate of Epirubicin which could result in a higher serum level. The metabolism of Ibuprofen can be decreased when combined with Efavirenz. The risk or severity of adverse effects can be increased when Fosinopril is combined with Ibuprofen. Ibuprofen may increase the neuroexcitatory activities of Grepafloxacin. The metabolism of Ibuprofen can be decreased when combined with Sertraline. The therapeutic efficacy of Polythiazide can be decreased when used in combination with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Tixocortol. Ibuprofen may decrease the excretion rate of Daunorubicin which could result in a higher serum level. The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Ibuprofen. The serum concentration of Imatinib can be decreased when it is combined with Ibuprofen. Ibuprofen may decrease the excretion rate of Gentamicin which could result in a higher serum level. The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Ibuprofen. The serum concentration of Vancomycin can be increased when it is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fludrocortisone. Ibuprofen may decrease the excretion rate of Neomycin which could result in a higher serum level. The metabolism of Ibuprofen can be decreased when combined with Amiodarone. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Clocortolone. Ibuprofen may decrease the antihypertensive activities of Bupranolol. The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Ibuprofen. The risk or severity of adverse effects can be increased when Omapatrilat is combined with Ibuprofen. The serum concentration of Lithium can be increased when it is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Niflumic Acid. Ibuprofen may decrease the antihypertensive activities of Metoprolol. Ibuprofen may increase the anticoagulant activities of Troxerutin. The therapeutic efficacy of Limaprost can be decreased when used in combination with Ibuprofen. Ibuprofen may decrease the antihypertensive activities of Nadolol. The metabolism of Ibuprofen can be decreased when combined with Fluoxetine. Ibuprofen may increase the neuroexcitatory activities of Pazufloxacin. The metabolism of Ibuprofen can be decreased when combined with Trimethoprim. Ibuprofen may increase the anticoagulant activities of Dicoumarol. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Felbinac. The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Ibuprofen. Ibuprofen may increase the anticoagulant activities of Dalteparin. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Estrone. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Flunisolide. Ibuprofen may decrease the excretion rate of Puromycin which could result in a higher serum level. Ibuprofen may increase the anticoagulant activities of Desirudin. Ibuprofen may increase the anticoagulant activities of Edetic Acid. Ibuprofen may decrease the antihypertensive activities of Landiolol. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fenbufen. Ibuprofen may decrease the antihypertensive activities of Bevantolol. Ibuprofen may decrease the diuretic activities of Torasemide. Ibuprofen may decrease the antihypertensive activities of Bisoprolol. The metabolism of Ibuprofen can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Rimexolone. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Anecortave. The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Ibuprofen. The therapeutic efficacy of Sulprostone can be decreased when used in combination with Ibuprofen. The therapeutic efficacy of Latanoprost can be decreased when used in combination with Ibuprofen. The risk or severity of adverse effects can be increased when Carprofen is combined with Ibuprofen. Ibuprofen may increase the anticoagulant activities of Apixaban. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fluprednidene. Ibuprofen may increase the anticoagulant activities of Ferulic acid. Ibuprofen may decrease the excretion rate of Sisomicin which could result in a higher serum level. The metabolism of Ibuprofen can be decreased when combined with Sulfisoxazole. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Technetium Tc-99m medronate. The risk or severity of adverse effects can be increased when Temocapril is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Zomepirac. The metabolism of Ibuprofen can be decreased when combined with Pyrimethamine. The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ibuprofen. Ibuprofen may decrease the excretion rate of Metrizamide which could result in a higher serum level. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Anisodamine. Ibuprofen may increase the anticoagulant activities of Pentaerythritol Tetranitrate. Ibuprofen may increase the neuroexcitatory activities of Gemifloxacin. Ibuprofen may decrease the excretion rate of Aclarubicin which could result in a higher serum level. The risk or severity of adverse effects can be increased when Salicylic acid is combined with Ibuprofen. The therapeutic efficacy of Alprostadil can be decreased when used in combination with Ibuprofen. The risk or severity of adverse effects can be increased when Moexipril is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Formestane. The serum concentration of Ibuprofen can be increased when it is combined with Voriconazole. The risk or severity of adverse effects can be increased when Ibuprofen is combined with 16-Bromoepiandrosterone. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Isoxicam. Ibuprofen may increase the neuroexcitatory activities of Gatifloxacin. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fluocortolone. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Choline magnesium trisalicylate. The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Ibuprofen. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Lornoxicam. The metabolism of Ibuprofen can be decreased when combined with Tamoxifen. Cholestyramine can cause a decrease in the absorption of Ibuprofen resulting in a reduced serum concentration and potentially a decrease in efficacy. The risk or severity of adverse effects can be increased when Ibuprofen is combined with Dexamethasone.